TECRL , a new life‐threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Genetic causes of many familial arrhythmia syndromes remain elusive. In this study, whole‐exome sequencing ( WES ) was carried out on patients from three different families that presented with life‐threatening arrhythmias and high risk of sudden cardiac death ( SCD ). Two French Canadian probands carried identical homozygous rare variant in TECRL gene (p.Arg196Gln), which encodes the trans ‐2,3‐enoyl‐CoA reductase‐like protein. Both patients had cardiac arrest, stress‐induced atrial and ventricular tachycardia, and QT prolongation on adrenergic stimulation. A third patient from a consanguineous Sudanese family diagnosed with catecholaminergic polymorphic ventricular tachycardia ( CPVT ) had a homozygous splice site mutation (c.331+1G>A) in TECRL . Analysis of intracellular calcium ([Ca 2+ ] i ) dynamics in human induced pluripotent stem cell‐derived cardiomyocytes (hi PSC ‐ CM s) generated from this individual ( TECRL H om ‐hi PSC s), his heterozygous but clinically asymptomatic father ( TECRL H et ‐hi PSC s), and a healthy individual ( CTRL ‐hi PSC s) from the same Sudanese family, revealed smaller [Ca 2+ ] i transient amplitudes as well as elevated diastolic [Ca 2+ ] i in TECRL H om ‐hi PSC ‐ CM s compared with CTRL ‐hi PSC ‐ CM s. The [Ca 2+ ] i transient also rose markedly slower and contained lower sarcoplasmic reticulum ( SR ) calcium stores, evidenced by the decreased magnitude of caffeine‐induced [Ca 2+ ] i transients. In addition, the decay phase of the [Ca 2+ ] i transient was slower in TECRL H om ‐hi PSC ‐ CM s due to decreased SERCA and NCX activities. Furthermore, TECRL H om ‐hi PSC ‐ CM s showed prolonged action potentials ( AP s) compared with CTRL ‐hi PSC ‐ CM s. TECRL knockdown in control human embryonic stem cell‐derived CM s ( hESC ‐ CM s) also resulted in significantly longer AP s. Moreover, stimulation by noradrenaline ( NA ) significantly increased the propensity for triggered activity based on delayed afterdepolarizations ( DAD s) in TECRL H om ‐hi PSC ‐ CM s and treatment with flecainide, a class Ic antiarrhythmic drug, significantly reduced the triggered activity in these cells. In summary, we report that mutations in TECRL are associated with inherited arrhythmias characterized by clinical features of both LQTS and CPVT . Patient‐specific hi PSC ‐ CM s recapitulated salient features of the clinical phenotype and provide a platform for drug screening evidenced by initial identification of flecainide as a potential therapeutic. These findings have implications for diagnosis and treatment of inherited cardiac arrhythmias.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gøtzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.03.004 · Cited by 1,858
Priori, S. G., Napolitano, C., Tiso, N., Memmi, M., Vignati, G., Bloise, R., Sorrentino, V., & Danieli, G. A. (2001) · Circulation · doi:10.1161/01.cir.103.2.196 · Cited by 1,378 · cited 1×
“Rare autosomal recessive mutations in the calcium-sequestering protein, CASQ2 (2–5% of all cases), account for a small fraction of CPVT population (Lahat et al, 2001; Laitinen et al, 2001; Priori et al, 2001; Postma et al, 2002).”
BackgroundLaitinen, P. J., Brown, K. M., Piippo, K., Swan, H., Devaney, J. M., Brahmbhatt, B., Donarum, E. A., Marino, M., Tiso, N., Viitasalo, M., et al. (2001) · Circulation · doi:10.1161/01.cir.103.4.485 · Cited by 726 · cited 1×
“Rare autosomal recessive mutations in the calcium-sequestering protein, CASQ2 (2–5% of all cases), account for a small fraction of CPVT population (Lahat et al, 2001; Laitinen et al, 2001; Priori et al, 2001; Postma et al, 2002).”
BackgroundLahat, H., Pras, E., Olender, T., Avidan, N., Ben-Asher, E., Man, O., Levy-Nissenbaum, E., Khoury, A., Lorber, A., Goldman, B., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/324565 · Cited by 655
A proposed charter for clinical trial data monitoring committees: helping them to do their job well
(2005) · The Lancet · doi:10.1016/s0140-6736(05)17965-3 · Cited by 324
Chan, A.-W., Hrobjartsson, A., Jorgensen, K. J., Gotzsche, P. C., & Altman, D. G. (2008) · BMJ · doi:10.1136/bmj.a2299 · Cited by 202
Cited by
Calcium Signaling and Cardiac Arrhythmias
Landstrom, A. P., Dobrev, D., & Wehrens, X. H. T. (2017) · Circulation Research · doi:10.1161/circresaha.117.310083 · Cited by 568
Wilde, A. A. M., Semsarian, C., Márquez, M. F., Shamloo, A. S., Ackerman, M. J., Ashley, E. A., Sternick, E. B., Barajas-Martinez, H., Behr, E. R., Bezzina, C. R., et al. (2022) · Europace · doi:10.1093/europace/euac030 · Cited by 380
Self-citationWilde, A. A. M., Semsarian, C., Márquez, M. F., Sepehri Shamloo, A., Ackerman, M. J., Ashley, E. A., Sternick, E. B., Barajas-Martinez, H., Behr, E. R., Bezzina, C. R., et al. (2022) · Heart Rhythm · doi:10.1016/j.hrthm.2022.03.1225 · Cited by 274
Self-citationSchwartz, P. J., Ackerman, M. J., Antzelevitch, C., Bezzina, C. R., Borggrefe, M., Cuneo, B. F., & Wilde, A. A. M. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0188-7 · Cited by 271
Self-citationPathogenic variants damage cell composition and single cell transcription in cardiomyopathies
Reichart, D., Lindberg, E. L., Maatz, H., Miranda, A. M. A., Viveiros, A., Shvetsov, N., Gärtner, A., Nadelmann, E. R., Lee, M., Kanemaru, K., et al. (2022) · Science · doi:10.1126/science.abo1984 · Cited by 240
“Collectively, disease remodeling of MC indicated modulation of PDGF and NOTCH signaling receptors and synthesis of selective ECM and integrin components.”
Metadata
- Authors
- Devalla, H. D., Gélinas, R., Aburawi, E. H., Beqqali, A., Goyette, P., Freund, C., Chaix, M., Tadros, R., Jiang, H., Le Béchec, A., Monshouwer‐Kloots, J. J., Zwetsloot, T., Kosmidis, G., Latour, F., Alikashani, A., Hoekstra, M., Schlaepfer, J., Mummery, C. L., Stevenson, B., Kutalik, Z., de Vries, A. A., Rivard, L., Wilde, A. A., Talajic, M., Verkerk, A. O., Al‐Gazali, L., Rioux, J. D., Bhuiyan, Z. A., & Passier, R.
- Venue
- EMBO Molecular Medicine
- Published
- 2016-10-24
- Volume
- 8
- Issue
- 12
- Pages
- 1390-1408
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- OpenAlex
- W2533344724
- Cited by
- 138
- References
- 6
- FWCI
- 9.21
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: TECRL , a new life‐threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT. https://app.cochat.ai/papers/10.15252/emmm.201505719
- The paper
- Devalla, H. D., Gélinas, R., Aburawi, E. H., Beqqali, A., Goyette, P., Freund, C., Chaix, M., Tadros, R., Jiang, H., Le Béchec, A., Monshouwer‐Kloots, J. J., Zwetsloot, T., Kosmidis, G., Latour, F., Alikashani, A., Hoekstra, M., Schlaepfer, J., Mummery, C. L., Stevenson, B., . . . Passier, R. (2016). TECRL , a new life‐threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT. EMBO Molecular Medicine. https://doi.org/10.15252/emmm.201505719
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.